Results 171 to 180 of about 79,111 (213)

Angiotensin II Receptor Blockers in Heart Failure

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
Heart failure remains a significant cause of morbidity and mortality, despite major advances in therapy. Angiotensin II, the principal mediator of the renin‐angiotensin system, exerts both short‐term (e.g., hemodynamic, renal) and long‐term (e.g., inflammation, cardiac remodeling) effects in the pathophysiology of cardiovascular disease. The effects of
openaire   +2 more sources

Angiotensin II Receptor Blockers in Older Patients

The American Journal of Geriatric Cardiology, 2004
Older patients with hypertension are often inadequately treated due to misconceptions regarding reasonable goal blood pressures or concerns about treatment side effects. Adequately treating hypertension can yield impressive benefits in terms of improved morbidity and enhanced quality of life in persons of any age. Antagonists of the renin‐
openaire   +2 more sources

Angiotensin II Receptor Blockers

2001
The angiotensin II (Ang II) receptor antagonists are the most selective blockers of the renin-angiotensin system (RAS) currently available. The efficacy of these drugs is similar to that of the other major antihypertensive drug classes, but they appear to exhibit fewer side effects. Angiotensin receptor blockers (ARBs) selectively block the angiotensin
openaire   +1 more source

Treating Hypertension with Angiotensin II Receptor Blockers

High Blood Pressure & Cardiovascular Prevention, 2005
The clinical use of angiotensin II receptor blockers (ARBs) has resulted in the effective and successful treatment of arterial hypertension, and vast experience has been gained by physicians in this original indication over the last years. Furthermore, promising results have been obtained with the use of ARBs in other clinical conditions, such as type ...
Luis M Ruilope, Massimo Volpe
openaire   +1 more source

Angiotensin II-receptor blockers: Clinical relevance and therapeutic role

American Journal of Health-System Pharmacy, 2001
The limitations of angiotensin-converting-enzyme (ACE) inhibitors and the role of angiotensin II-receptor blockers (ARBs) in the treatment of hypertension, heart failure, and diabetic nephropathy are discussed. Although ACE inhibitors are generally well tolerated, two important class-related adverse effects are cough, which is common, and angioedema ...
J E, Rodgers, J H, Patterson
openaire   +2 more sources

Effects of angiotensin II receptor blockers on diabetic nephropathy

Journal of Hypertension, 2009
Impaired kidney function increases the risk of cardiovascular morbidity and mortality. Coexistence of hypertension and type 2 diabetes increases the risk of kidney damage, hypertension being an independent risk factor for kidney disease progression. Angiotensin II, through its inflammatory, proliferative, and thrombotic effects, adversely affects renal
Rigas, Kalaitzidis, George L, Bakris
openaire   +2 more sources

Vascular and metabolic effects of angiotensin II receptor blockers

Expert Opinion on Pharmacotherapy, 2009
Angiotensin II receptor blockers (ARBs) are widely used in patients with hypertension, heart failure and type 2 diabetes mellitus (T2DM). Several large clinical trials have demonstrated that these agents are effective in reducing cardiovascular mortality and morbidity.
Silvia, Barra, Alice, Vitagliano, Vittoria, Cuomo, Giancarlo, Vitagliano, Giovanni, Gaeta   +4 more
openaire   +2 more sources

Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

2014
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) play a pivotal role in the management of heart failure (HF) and hypertension. These agents are mildly cardioprotective and increase survival somewhat in patients with:
openaire   +1 more source

Angiotensin II receptor blockers

Coronary Artery Disease, 1999
H, Thai, T, Raya
openaire   +2 more sources

Frictional purpuric eruption associated with angiotensin II receptor blockers.

Dermatologic therapy, 2014
Angiotensin II receptor blockers (ARBs) are drugs generally well tolerated. There are few reports about cutaneous side effects of ARBs. The present authors describe herein four cases of purpuric eruption mainly involving sites of friction in patients taking ARBs.
Foti, C., Carbonara, A. M., GUIDA, STEFANIA, Antelmi, A., Mazzocca, A., Romita, P., Bonamonte, D., Angelini, G.   +7 more
openaire   +3 more sources